本頁面由Tiger Trade Technology Pte. Ltd.提供服務

美第奇新星生物技術

1.81
+0.07004.02%
盤後1.810.00000.00%19:30 EDT
成交量:4.60萬
成交額:8.28萬
市值:8,895.47萬
市盈率:-8.27
高:1.84
開:1.73
低:1.73
收:1.74
52周最高:1.96
52周最低:1.17
股本:4,914.62萬
流通股本:4,349.65萬
量比:0.44
換手率:0.11%
股息:- -
股息率:- -
每股收益(TTM):-0.2188
每股收益(LYR):-0.2445
淨資產收益率:-25.56%
總資產收益率:-16.41%
市淨率:2.39
市盈率(LYR):-7.40

資料載入中...

2024/06/12

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/01

重要事件披露

Form 8-K - Current report
2024/02/15

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/01/20

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/20

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/20

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/01/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2023/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/07

重要事件披露

Form 8-K - Current report
2023/06/22

重要事件披露

Form 8-K - Current report
2023/06/14

重要事件披露

Form 8-K - Current report
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/26

重要事件披露

8-K - Current report
2023/03/28

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/16

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/11/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/09/01

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]